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Fever  is  mediated  by  an  endogenously  produced  low  molecular  weight  protein 
called leukocytic pyrogen (LP),  1 which acts in or near the thermoregulatory center of 
the  pre-optic  anterior  hypothalamus  (1).  Human  LP  is  synthesized  by phagocytic 
leukocytes after stimulation  by a  variety of substances;  however, with the exception 
of certain  pyrogenic steroids,  these  substances  have  been  microbial  agents  or their 
products (2). In studies on immunologically mediated fever, the use of soluble antigens 
or antigen-antibody complexes to stimulate LP in sensitized animals is well established 
(3-5). On the other hand, antigens have not been demonstrated  to stimulate human 
LP production  even when  antigens  such as tetanus  toxoid,  penicillin,  or tuberculin 
are  incubated  with  leukocytes from known sensitized  individuals  in the presence of 
autologous  serum.  Thus,  the  mechanism  of  LP  production  in  immunologically 
mediated  febrile disease in humans remains unexplained.  The present  investigations 
concern the role of alloantigens  in the stimulation  of LP production and the results 
demonstrate  the  release  of a  soluble  factor in the mixed  leukocyte reaction  (MLR) 
that induces the synthesis of LP from human monocytes. This factor was produced in 
the  absence  of materials  of microbial  or plant  origin,  and  its  ability  to  induce  LP 
synthesis  may  be  important  in  the  pathogenesis  of fever  in  humans  with  certain 
immunologically mediated diseases. 
Materials  and Methods 
Cell Cultures.  Methods concerning pyrogen-free materials  and pyrogen testing have been 
described elsewhere (6, 7). Heparinized human blood was obtained from donors, mixed with 
pyrogen-free  saline  and  separated  on  Ficoll-Hypaque  gradients  in  50-ml  tubes  (8). The 
mononuclear cell  layer was  aspirated,  washed  twice  in  saline,  and  resuspended  in  Eagle's 
minimum essential medium (MEM;  Microbiological Associates,  Walkersville, Md.). The cell 
6  5  concentration was adjusted to either 5 ×  10  or 5 ×  10  cells/ml in MEM containing 10% heat- 
activated AB serum and then aliquoted  into  1-ml  volumes in  17- ×  100-mm polypropylene 
tubes  (Falcon Labware,  Div.  of Becton,  Dickinson  & Co., Oxnard,  Calif.).  Cells  from each 
donor were then combined to produce a MLR; the final volume for the MLR or autologous 
individual control cultures was 2 ml/tube. Additional controls were 2 ml MEM or MEM with 
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10% AB serum. All tubes were incubated for 2-7 d  in a  stationary incubator at 37°(] in 5% 
(]O~. In other experiments, mononuclear cells were incubated in 16-ram diameter flat-bottomed 
wells ((]ostar, Data Packaging, Cambridge, Mass.)  in 2-ml volumes. Under these conditions, 
cells were  aliquoted  and  mixed  in  tubes  and  then  transferred  to  flat-bottomed wells  for 
incubation.  For the  in  vitro  production  of LP,  blood  and  processing methods  have  been 
described (9,  10). To stimulate LP production with MLR supernates, these supernates were 
first diluted with Hanks' balanced salt solution (HBSS) and then mononuclear cells from a 
third donor were added to make a final concentration of 5 ×  10n/ml at the appropriate dilution 
of the MLR supernate. As controls for the ability  of these cells to be activated for LP production, 
phagocytosis of heat-killed Staphylococcus albus was used  (9).  After  18  h,  all supernates were 
removed, spun at 2,500 g  for 30 min, and tested in rabbits. 3-4 rabbits were each given an 
intravenous injection of the supernate from 2.0 ×  10  n monoeytes. Plateletphoresis by-products 
were occasionally used  for LP  production.  These  cell mixtures  were comprised of 40-50% 
monoeytes, 30-40% lymphocytes, and 5-10% neutrophils. Because of centrifugation methods 
used in plateletphoresis, cells consistently contained a  high percentage of monoeytes. Because 
previous studies had demonstrated that the monoeytes were essentially the only source of LP in 
these preparations (9) and that lymphocytes do not produce LP (10),  the monocytes were not 
separated from lymphocytes for the production of LP. 
Lymphocyte Studies.  Incorporation  of  [3H]thymidine  was  used  to  determine  lymphocyte 
proliferation in MLR  and autologous leukocyte cultures. After the mononuclear cells from 
different or the same  donors were combined in  17-  ×  100-ram  tubes,  200-~1 aliquots were 
removed and placed in round-bottomed microtiter plates (Falcon Labware) in quadruplicate. 
These were incubated at  37°(]  in  5% CO2  for the same number of days as the MLR  tube 
cultures. The amount  of [aH]thymidine incorporated into DNA-protein was determined by 
liquid scintillation and expressed as the difference of the mean number of counts per minute in 
four wells subtracted from wells with media alone. 
For adherence studies, mononuclear cells from donors were suspended in MEM with  10% 
heat-inactivated AB serum at 5 X 106 cells/ml. These were warmed at 37°(], plated out in 5-ml 
volumes onto 85-ram diameter plastic petri dishes (Falcon Labware) and incubated for 2 h at 
37°(].  Nonadherent  cells were  poured off and  the  plates were washed  with  5  ml  of warm 
medium. Cells from the wash were pooled with the first harvest nonadherent population and 
the concentration of cells was adjusted to 5 x  10n/ml before combining individual donors in 
the MLR. Nylon wool adherence was carried out in columns filled with MEM containing 10% 
AB serum and incubated at 37°C  for 60 min.  1 X  10  s mononuelear cells in 2 ml of MEM/ 
serum were applied to columns and allowed to enter the nylon wool. They were incubated for 
1 h at 37°(] and nonadherent cells were eluted with 30 ml of warmed medium/serum. 
Results 
Presence of a Pyrogen-inducing Factor in  Two-Way MLR Supernates.  MLR  supernates 
obtained after 2-7 d of incubation were diluted with HBSS and then added to human 
monocytes from a  third donor not used in the original MLR. These suspensions were 
incubated in 25-ml flasks at 37°C  for  18  h  and tested for the presence of LP.  Fig.  1 
illustrates such an experiment and Table I depicts 14 separate MLR  experiments that 
were  studied  in  this  manner.  As  shown  in  Table  I,  when  MLR  supernates  were 
injected into rabbits they occasionally produced fevers (4 out of 14). The fevers were 
characterized by rapid onset and  monophasia,  indicating that  various quantities of 
LP were present in these supernates.  However, when  MLR  supernates were diluted 
(1:10) to subpyrogenic levels, added to the monocytes of a third donor, and incubated 
for  18  h,  LP was induced in  12 of the  14  MLR  supernates studied  (Table I). Fever 
observed in these 18-h incubations was not due to small amounts of LP present in the 
MLR  supernate itself. These MLR  supernates could be diluted  1:20 and still induce 
significant amounts of LP (Fig.  1). Additional experiments were carried out in which 
the  cell concentration  of the  MLR  was  reduced  from  5  ×  106/ml  to  5  ×  10~/ml. CHARLES A.  DINARELLO  1217 
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FIG.  1.  Mean ±  SEM peak rectal temperature, AT, (°C) over baseline (3-4 rabbits/experiment) 
during a 2-h period after injection. This experiment represents a single MLR supernate obtained 
after 3 d at 37°C. Dilutions (1:10 and 1:20) of  supernate from MLR with and without mononuclear 
cells are present in the first four bars. Each rabbit received the supemate from 2.0 ×  100 monocytes 
stimulated with materials indicated on the abscissa. 
TABLE  I 
Febrile Responses of Rabbits to Human LP Induced by MLR Supemates 
Donors*  Time:l:  MLR super-  Monocytes§ +  MLR super-  Monocytes§ + 
nat~  nate[[  staphylococci 
L.R. ×  D.B.  2  0.00¶  0.51 ±  0.11  0.72 ± 0.13 
R.M. × A.D.  3  0.50  0.67 ±  0.03  0.65 ±  0.05 
K.M. ×  S.S.  3  0.00  0.85 ±  0.09  0.65 ±  0.05 
A.D. × T.B.  3  0.00  0.52 ± 0.13  1.00 ± 0.00 
E.K. ×  P.W.  4  0.83 +  0.15  0.93 + 0.08  0.75 ±  0.06 
P.P. ×  R.C.  5  0.61 ± 0.07  0.63 ±  0.10  0.76 ± 0.08 
P.A. ×  S.B.  5  0.00  0.64 ± 0.13  0.93 ± 0.09 
C.D. ×  B.D.  5  0.00  0.53 ± 0.12  0,85 ± 0.05 
K.G. ×  R.S,  5  0.00  0.00  0.71 ±  0.06 
R.M. ×  L.B.  5  0.00  0.00  0.65 ±  0.02 
R.C. × J.H.  7  0.00  0.96 ±  0.05  0.82 ± 0.10 
H.B. ×  S.B.  7  0.28 ±  0.12  0.95 ± 0.11  1.03 ± 0.13 
C.D. × C.F.  7  0,64 ±  0.09  0.92 ± 0,08  1.12 ± 0.15 
R.M. × A.D.  7  0.57 ± 0.07  0.52 ± 0.08  0.65 ±  0.05 
* Initials of the normal volunteer donors whose cells were used in MLR. 
Number of days of MLR incubation. 
§ 5 ×  10  s cells/mi. 
[] Diluted 1:10 before addition to monocytes. 
¶ Data are expressed as the mean  ±  SEM  peak  temperature (°C)  elevation over 
baseline in 3-4 recipient rabbits. 
Under  these conditions, MLR  supernates did not contain detectable levels of LP but 
nevertheless stimulated LP production. 
Because of the possibility that subpyrogenic quantities of LP produced in the MLR 
supernate  could  induce  subsequent  LP  production,  experiments  were  designed  to 
remove or destroy any LP present. Supernates from two separate MLR  cultures were 
tested for their ability to induce LP before and  after passage over a  rabbit antibody 
to  human  LP  coupled  to  Sepharose 4B  (11).  In  addition,  the MLR  supernate  was 
heated at 56°C for 30 min, which destroys LP. As shown in Fig. 2, neither procedure 1218  HUMAN  PYROGEN-INDUCING  LYMPHOKINE 
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Fzo. 2.  Mean 3= SEM peak febrile responses,  AT, (°C) over baseline of 6-8 rabbits. Each rabbit 
received the supernate from 2.0  X  10  6 monocytes stimulated with materials indicated under the 
abscissa. A pool of MLR supernates was used in these studies. This pool was passed over an anti-LP 
immunoadsorbent (see Materials and Methods) on two separate occasions.  This immunoadsorbent 
had the ability to bind 200 rabbit pyrogen doses.  (A rabbit pyrogen dose is defined as the amount 
of LP that produces a peak temperature rise of 0.6-0.9°C over baseline [7]). The LP used as control 
in  these experiments  (three bars on  the right)  was  obtained from crude supernates of human 
monocytes stimulated by phagocytosis of heat-killed staphylococci. 
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Fro.  3.  Mean  +  SEM  peak  febrile responses, AT,  (°C) over baseline of nine recipient rabbits 
injected with supernates from human mononuclear cells stimulated for 18 h with materials indicated 
on  the abscissa. These results represent the mean of three separate MLR experiments using six 
individual donors. MLR supernates prepared from unfractioned mononuclear cells were compared 
to supernates of the same paired donors prepared from cells purified over adherence to plastic and 
passage over nylon wool.  In addition, the plastic adherent cells from each donor were also used in 
three paired MLR experiments. In each of the three experiments, cells were reconstituted in an 
MLR. Each rabbit was injected with the supernate of 2.0 ×  10  e monocytes obtained from another 
donor. Three rabbits were used to assay the LP in each supernate for a total of nine rabbits for each 
bar shown (see text). 
altered  the  ability  of  MLR  supernate  to  induce  LP  production.  Therefore,  the 
pyrogen-inducing  factor was not due to LP  itself. 
Source of the Pyrogen-inducing Factor.  Several experiments  were carried out  to deter- 
mine  the  cellular  requirements  necessary  for  the  release  of  this  pyrogen-inducing 
factor. Removal  of adherent  cells by incubation  of plastic surfaces either had no effect 
or  only  slightly  diminished  the  amount  of  the  pyrogen-inducer  released  into  the 
supernate. In further experiments, removal of cells using adherence  to plastic, followed 
by exposure  to nylon wool, was employed.  Nylon wool-purified cells did not produce 
this factor when  cultured  in  the MLR  (Fig.  3).  To  determine  whether  the adherent CHARLES  A.  DINARELLO  1219 
cell population was the source of the pyrogen-inducing factor, adherent  cells were 
removed from the plastic at  4°C  using a  rubber spatula.  Adherent cells from two 
separate donors did not produce this factor when mixed together and incubated for 
3  d,  although  these  adherent  cells  were  still  viable  because  they  phagocytized 
staphylococci. However, when adherent cells were added back to nylon-purified cells 
at a ratio of 1  : 10 in a reconstituted MLR, the factor reappeared (Fig. 3). These results 
indicate that both T  cells and monocytes are necessary for the release of this factor 
and are consistent with antigen presentation by macrophages and the elaboration of 
a lymphokine from T  cells. 
Characterization of the Pyrogen-indacing Factor.  The pyrogen-inducing factor present 
in the MLR supernates was retained by autoclaved dialysis tubing against 4,000 vol 
of medium at 4°C for 24 h. Heating supernates at  70°C for 30 min destroyed their 
ability to induce LP production, whereas heating for 56°C for 30 rain had no effect 
(Fig. 2). MLR supernates were consistently negative in the Limulus amebocyte assay 
test. In addition, MLR incubated at 4°C for 3 d did not release the factor. 
Although LP from human cells produces fever in many species (rabbits, monkeys, 
mice,  and  eats),  species  specificity for the  pyrogen-inducing  factor is  not  known. 
Experiments were designed to incubate rabbit monocytes with human MLR super- 
hates  and  test  for  rabbit  LP  production.  Rabbit  blood  mononuclear  cells  were 
obtained from FicoU-Hypaque gradients of rabbit blood as described for human cells 
in Materials and Methods. A pool of human MLR supernate was diluted  1:I0 with 
rabbit mononuclear cells at 5 X  106 cells/ml. In addition to stimulation by phagocy- 
tosis, human AB serum  (10% vol/vol) was used as a  control. Supernates from these 
incubations were injected into rabbits at volumes comparable to the supernate from 
2.5 X  l0  T  rabbit monocytes. As shown in Fig. 4, human MLR supernates were capable 
of stimulating rabbit LP production from monocytes. 
Comparison of Lymphocyte DNA Synthesis with Elaboration of Pyrogen-inducing Factor.  The 
two-way  MLR  is  associated  with  increased  lymphocyte proliferation  presumably 
induced by the presence of  surface membrane glycoprotein alloantigens. In an attempt 
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Fla.  4.  Mean  =l=  SEM  ~aeak febrile  response,  AT,  (°C)  of six  recipient  rabbits  injected  with 
supernates from 2.5  ×  10  rabbit monocytes incubated with various materials as indicated on the 
abscissa. These results are the mean of two experiments using a  pool of MLR supernate diluted 
1:10 with monocytes obtained on two separate occasions from four different rabbits. Because human 
AB serum may stimulate rabbit LP production, a  control of AB serum to a  final concentration of 
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to correlate lymphocyte proliferation with the release of the pyrogen-inducing  factor, 
increased thymidine incorporation into new DNA-synthesis was measured in the two- 
way MLR. The data in Table II indicate that lymphocyte proliferation occurs, and 
in three of the five experiments was associated with, the elaboration of the pyrogen- 
inducing factor.  However,  this  factor  was  present  in an  MLR  supernate before  a 
significant proliferative response took place, and was absent in two experiments in 
which significant proliferation had occurred. Therefore, the release of this factor does 
not always correlate with lymphocyte proliferation in the MLR. 
In  another  set  of  experiments,  the  production  of  this  factor  from  individual 
leukocyte cultures was examined. In early studies, small quantities of this factor were 
detected occasionally in 5-7-d cultures of the individual donors, but this finding was 
attributed to nonspecific stimulatory effects. Using heat-inactivated autologous serum 
in these cultures, it was observed that certain individuals occasionally produced the 
pyrogen-inducing  factor in the absence of allogeneic stimulation. When these individ- 
uals  were  restudied  at  a  later  time,  this  finding could  not  always  be  repeated. 
However, autologous leukocyte cultures of two other donors were tested at concentra- 
tions of 5  X  108 and 5  ×  105/ml in either round-bottomed tubes or  flat-bottomed 
wells. Under the latter conditions, the pyrogen-inducing factor was not present after 
culture of autologous leukocytes. However, regardless of cellular concentration, the 
factor was present in the supernates of the MLR of these donors. 
TABLE II 
[all] Thymidine Incorporation and Presence of Pyrogen-inducing Factor in the 
MLR 
Monocytes§ + 
Donor*  Time:~  A CPM  MLR supernatell 
R.M.  2  605 + 124  0.00¶ 
D.F.  2  361 ± 126  0.00 
R.M. × D.F.  2  2,935 4-424  0.65 4- 0.12 
P.A.  3  642 4- 192  0.00 
S.B.  3  1,229 4- 32  0.00 
P.A. × S.B.  3  15,415 4- 2,015  0.64 ± 0.13 
C.D.  5  19,456 4- 891  0.00 
G.T.  5  11,260 ± 793  0.00 
C.D. x G.T.  5  141,913 4- 18,460  0.00 
K.G.  5  2,310 4- 328  ND** 
D.E.  5  247 4- 55  ND 
K.G. × D.E.  5  20,516 4- 4,157  0.00 
B.S.  5  345 + 75  0.00 
D.D.  5  1,428 4- 142  0.00 
B.S. × D.D.  5  25,642 ±  1,281  0.53 ± 0.14 
A.M.  5  1,612 ± 51  0.00 
T.B.  5  511 ± 73  0.00 
A.M. X T.B.  5  6,468 -t- 137  0.80 ± 0.11 
* Initials of the normal volunteer donors whose cells were used in the MLR. 
~: Number of days of MLR incubation. 
§ 5 ×  l0  s cells/ml. 
II Diluted 1:5 before added to cells. 
¶ Data are expressed as the mean + SEM peak temperature (°C) elevation 
over baseline in 3-4 recipient rabbits. 
** Not done. CHARLES A. DINARELLO  1221 
Discussion 
The  pathogenesis  of  fever  in  humans  has  been  studied  using  microbial  and 
nonmicrobial substances that induce the release of LP from human phagocytic cells 
in vitro. In general, agents such as bacterial lipopolysaccharide (LPS)  from Gram- 
negative bacteria, bleomycin, and etiocholanolone have been shown to produce fever 
in vivo in humans and induce LP production in vitro (2).  Studies on nonmicrobial, 
immunologically  mediated  fever,  such  as  drug  allergy,  have  not  been  reported, 
although there is hardly a dearth of  patients with fever associated with hypersensitivity 
to specific antigens. Therefore, there is presently no model for studying the mechanism 
of immunologically mediated  fever in  humans.  On  the other hand, several experi- 
mental  models  exist  in  animals.  These  include  sensitizing  animals  with  specific 
antigens  and  after subsequent  challenge,  evoking a  febrile response.  At  least  two 
mechanisms seem to be involved in the pathogenesis of immune fever in animals. One 
involves the  requirement  for circulating antibody in which antigen-antibody com- 
plexes bring about the production of LP (5).  The other is cell-mediated and can be 
transferred with sensitized cells (12). Further studies on cell-mediated immune fever 
have established that a factor is liberated from sensitized lymphocytes when exposed 
to an antigen that stimulates LP production (13). However, whether these mechanisms 
play a  role in immunologically mediated fever in humans remains unclear, and the 
inability of several antigens (tetanus toxoid, penicillin, and old tuberculin) to induce 
LP production from cells to sensitized individuals has hampered these efforts. 
The current experiments demonstrate that  LP synthesis from human  monocytes 
can  be induced  by soluble  factor  (or  factors)  produced  in  the  human  MLR.  The 
stimulation for the release of this substance appears to be the presence of allogeneic 
cells in the two-way MLR. The importance of the present study, in addition to the 
fact that materials from humans were employed, is that alloantigens, not microbial or 
plant  products,  were used  to stimulate  the release of the  pyrogen-inducing factor. 
Thus, the present experiments may be similar to allogeneic stimulation seen in graft- 
vs.-host disease or transplant  rejection. In these immunologically mediated diseases, 
fever is a prominent sign and the production of this factor from human lymphocytes 
in the MLR may aid in understanding the pathogenesis of fever in these and other 
immunologieally related diseases. 
The physical nature of the pyrogen-inducing substance is unknown except that it 
is retained by autoclaved dialysis membrane and destroyed at  70°C for 30 min. LP 
was occasionally detected in the MLR supernate after 3-5 d, and most likely represents 
the stimulation of monocytes present in the MLR. However, removal of LP using an 
immobilized antibody to LP demonstrated that the pyrogen-inducing substance was 
not due to LP itself. This latter finding is important because there is evidence that 
large amounts of LP infused into rabbits induce the production of additional LP in 
vivo (14). Furthermore, the fact that LP is inactivated at 56°C for 30 min is further 
evidence that this factor is not LP itself. The fact that the human pyrogen-inducing 
lymphokine released during an MLR also induced the production of LP in rabbit 
monocytes suggests that this factor may not be species specific. 
The present  experiments also  demonstrate that  the pyrogen-inducing factor is  a 
product of lymphocytes, most likely T  cells. Other lymphokines, namely macrophage 
migration inhibitory factor, has been shown to be a  product of B  and T  cells  (15). 
Adherence of cells  to plastic  had  no significant  effect upon  the  generation of this 1222  HUMAN PYROGEN-INDUCING  LYMPHOKINE 
factor. With the double technique of adherence to plastic, followed by purification 
over nylon wool, the pyrogen-inducing factor was consistently absent from the MLR 
supernates in several experiments. Reconstitution of nylon wool-purified lymphocytes 
with adherent cells from each donor resulted in the reappearance of this factor in the 
MLR supernates. These findings are consistent with other reports demonstrating the 
requirement  of adherent  cells in  the  MLR  (16,  17), and  other T  cell recognition 
studies (18).  Although the stimulation for the release of this material appears to be 
the presence of allogeneic cells in the two-way MLR, release of this pyrogen-inducing 
factor was occasionally observed in the absence of allogeneic stimulation. This latter 
observation may be due to conditions of in vitro culture. Such conditions have been 
described by others and include cell density and geometry of the culture vessel, both 
of which may contribute to cellular interaction and stimulation in vitro (19). Reduc- 
tion of cell concentration or the use of flat culture surfaces prevented the spontaneous 
production of the pyrogen-inducing factor. 
Although these studies are the first to show the presence of a  pyrogen-inducing 
factor in  the  supernates  of MLR from human  cells,  they are  consistent  with  the 
findings of Bernheim et al.  (20) and Atkins et al.  (13), in which a pyrogen-inducing 
product of concanavalin A  (Con A) or antigen-stimulated lymphocytes was demon- 
strated. However, the use of plant products such as Con A in fever studies, and, in 
particular,  in  inducing  LP  production  in  vitro,  depends  on  the  availability  of 
preparations  free  of LPS  (21).  Recent  reports  from  the  present  laboratory  have 
provided evidence that sequentially purified human LP activates murine T  cells and 
thymocytes, properties similar to those of lymphocyte activating factor (22, 23). Other 
investigations have  also shown similar results using rabbit  LP  (24).  Although the 
characterization and identification of the specific pyrogen-inducing lymphokine in 
the MLR is presently unknown, activators of other macrophage functions by lym- 
phokines have been described (25, 26) and should be carefully investigated for their 
ability to contain LP or induce LP production. 
Summary 
The role of lymphocytes in the pathogenesis of fever was investigated by stimulating 
human blood mononuclear cells in a two-way mixed leukocyte reaction (MLR). After 
2-7 d of incubation, MLR supernates contained a factor that was not pyrogenic itself 
when injected into rabbits; however, these supernates, when incubated with human 
blood  monocytes from a  third  donor,  induced the synthesis of LP.  The  pyrogen- 
inducing activity was stable at 56°C, destroyed at 70°C, and was neither dialyzable 
nor removable by adsorption by anti-human leukocytic pyrogen  (LP)  attached to 
Sepharose  4B.  Production of this  factor was  not  always correlated with  increased 
thymidine incorporation in  the MLR.  Its production was absent when peripheral 
lymphocytes were purified over nylon wool. The concentration of mononuclear cells 
in the MLR varied from 5 ×  105 to 5 ×  106/ml in round-bottomed tubes. Under the 
latter conditions, some donor cells produced this factor without stimulation in the 
MLR culture, but when these cells were cultured on flat-bottomed containers at low 
cell concentration, autologous production was not observed. These experiments dem- 
onstrate the production of a human lymphocyte factor (lymphokine) that induces LP 
synthesis. This pyrogen-inducing lymphokine may be important in the pathogenesis 
of fever in certain immunologically mediated diseases. CHARLES A. DINARELLO  1223 
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